av/protalix-biotherapeutics--big.svg

COM:PROTALIX

Protalix Biotherapeutics

  • Stock

USD

Last Close

1.66

22/11 21:00

Market Cap

82.11M

Beta: -

Volume Today

545.62K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
11.51M
-
15.16M
31.68%
4.36M
71.21%
9.20M
110.79%
19.24M
109.17%
34.24M
77.94%
54.69M
59.73%
62.90M
15.00%
38.35M
39.03%
47.64M
24.22%
65.49M
37.48%
cost of revenue
5.43M
-
9.05M
66.78%
730K
91.94%
8.40M
1,050.41%
15.23M
81.36%
9.30M
38.93%
10.89M
17.13%
10.87M
0.20%
16.35M
50.36%
19.59M
19.84%
22.98M
17.30%
gross profit
6.08M
-
6.11M
0.36%
3.63M
40.49%
801K
77.96%
4.01M
400.75%
24.94M
521.74%
43.80M
75.63%
52.02M
18.78%
22.00M
57.71%
28.05M
27.48%
42.51M
51.58%
selling and marketing expenses
8.98M
-
15.87M
76.72%
16.24M
2.33%
16.75M
3.16%
25.29M
51.01%
40.42M
59.81%
general and administrative expenses
8.38M
-
1.94M
-
-5.97M
407.89%
-5.09M
14.73%
-4.02M
20.99%
-13.58M
237.84%
-25.46M
87.46%
selling general and administrative expenses
8.38M
-
9.66M
15.22%
7.28M
24.66%
9.36M
28.53%
11.53M
23.24%
10.92M
5.33%
9.90M
9.32%
11.15M
12.62%
12.73M
14.18%
11.71M
8.00%
14.96M
27.73%
research and development expenses
24.82M
-
21.65M
12.76%
20.02M
7.51%
24.61M
22.89%
28.83M
17.17%
33.33M
15.59%
44.62M
33.86%
38.17M
14.45%
29.73M
22.10%
29.35M
1.29%
17.09M
41.76%
other expenses
cost and expenses
38.63M
-
40.36M
4.49%
28.03M
30.55%
42.36M
51.11%
55.59M
31.24%
53.55M
3.68%
65.41M
22.15%
60.19M
7.98%
58.81M
2.29%
60.65M
3.13%
55.03M
9.26%
operating expenses
33.20M
-
31.31M
5.69%
27.30M
12.80%
33.96M
24.39%
40.36M
18.84%
44.25M
9.62%
54.52M
23.21%
49.31M
9.54%
42.46M
13.89%
41.06M
3.30%
32.05M
21.94%
interest expense
-674K
-
4.93M
832.20%
3.73M
24.32%
10.66M
185.54%
9.72M
8.81%
7.68M
20.98%
7.97M
3.66%
9.67M
21.40%
7.52M
22.23%
2.53M
66.37%
3.18M
25.74%
ebitda
-23.58M
-
-25.01M
6.07%
-23.55M
5.84%
-30.59M
29.91%
-36.16M
18.22%
-18.77M
48.09%
-8.69M
53.69%
3.15M
136.21%
-20.06M
737.26%
-10.78M
46.25%
11.65M
208.06%
operating income
-27.12M
-
-25.20M
7.05%
-23.67M
6.09%
-33.16M
40.11%
-36.35M
9.62%
-19.31M
46.89%
-10.72M
44.49%
1.85M
117.22%
-20.46M
1,208.45%
-13.01M
36.40%
10.46M
180.37%
depreciation and amortization
3.54M
-
3.14M
11.27%
2.37M
24.52%
1.98M
16.33%
1.92M
3.18%
1.67M
12.97%
2.02M
21.13%
1.30M
35.67%
401K
69.20%
2.23M
456.61%
1.19M
46.64%
total other income expenses net
-674K
-
-4.74M
603.12%
-3.61M
23.78%
14.06M
489.34%
-39.39M
380.07%
-7.15M
81.85%
-7.56M
5.74%
-8.37M
10.72%
-7.12M
14.92%
-1.38M
80.58%
-1.89M
36.95%
income before tax
-27.79M
-
-29.94M
7.75%
-27.28M
8.89%
-29.18M
6.94%
-85.28M
192.28%
-26.46M
68.97%
-18.28M
30.92%
-6.52M
64.31%
-27.58M
322.84%
-14.40M
47.80%
8.57M
159.50%
income tax expense
-2.94M
-
-87.57M
2,874.39%
10.85M
112.40%
7.80M
28.09%
536K
93.13%
7.97M
1,386.19%
8.37M
5.06%
6.40M
23.49%
530K
91.72%
254K
52.08%
net income
-27.79M
-
-29.94M
7.75%
58.04M
293.82%
-29.36M
150.60%
-85.28M
190.40%
-26.46M
68.97%
-26.24M
0.81%
-14.89M
43.25%
-33.98M
128.21%
-14.93M
56.08%
8.31M
155.68%
weighted average shs out
92.37M
-
92.89M
0.57%
94.92M
2.19%
101.39M
6.81%
13.11M
87.07%
14.71M
12.24%
14.84M
0.85%
29.15M
96.44%
44.14M
51.43%
48.47M
9.81%
82.42M
70.04%
weighted average shs out dil
92.37M
-
92.89M
0.57%
94.92M
2.19%
101.39M
6.81%
13.11M
87.07%
14.71M
12.24%
14.84M
0.85%
29.15M
96.44%
44.14M
51.43%
48.47M
9.81%
82.42M
70.04%
eps
-0.30
-
-0.32
6.67%
0.61
290.62%
-0.29
147.54%
-6.51
2,144.83%
-1.80
72.35%
-1.77
1.67%
-0.51
71.19%
-0.77
50.98%
-0.31
59.74%
0.12
138.71%
epsdiluted
-0.30
-
-0.32
6.67%
0.61
290.62%
-0.29
147.54%
-6.51
2,144.83%
-1.80
72.35%
-1.77
1.67%
-0.51
71.19%
-0.77
50.98%
-0.31
59.74%
0.09
127.97%

All numbers in USD (except ratios and percentages)